Epithelioid sarcoma

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Epithelioid sarcomas are rare mesenchymal tumors with unknown origins, distinct from synovial sarcoma and carcinoma.
• Accounting for less than 1% of soft tissue sarcomas, they predominantly affect young adult men and occur in extremities.
• Characterized by slow growth, histological nodules with central necrosis, and specific cellular morphology.

Purpose of the Study:

• To provide a comprehensive overview of epithelioid sarcomas, including their histogenesis, clinical presentation, and diagnostic markers.
• To differentiate epithelioid sarcomas from other soft tissue tumors.
• To highlight the prognostic factors and aggressive nature of certain variants.

Main Methods:

• Histological examination of tumor nodules.
• Immunohistochemical staining for vimentin, cytokeratins, epithelial membrane antigen, CD34, S100, desmin, and FLI-1.
• Ultrastructural analysis to identify epithelial and mesenchymal features.
• Review of cytogenetic findings, particularly abnormalities in the 22q region.

Main Results:

• Epithelioid sarcomas express vimentin, cytokeratins, EMA, and CD34; typically negative for S100, desmin, and FLI-1.
• Ultrastructural findings reveal both epithelial and mesenchymal characteristics, including myofibroblastic differentiation.
• No specific cytogenetic findings, but chromosomal abnormalities in 22q have been observed.
• High recurrence rate (nearly 100%) and metastatic potential (up to 50%).

Conclusions:

• Epithelioid sarcomas are unique tumors with multidirectional differentiation, lacking a normal cellular counterpart.
• The proximal variant is associated with a more aggressive clinical course.
• Early diagnosis and understanding of prognostic factors are crucial for managing epithelioid sarcomas due to their high recurrence and metastasis rates.